Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Explore practical guidance on the first crypto to buy as a beginner, including risk considerations and a simple decision framework.
26,337 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
I once believed SpaceX would be a slam-dunk winner for investors. Then I realized a careful, staged approach beats ri...
With $1,000, you can build a resilient, diversified starter portfolio. This guide shows how to pick the best stocks w...
Salesforce and Palantir posted strong quarters, but the market rewards or punishes them based on cash-return potentia...
Hycroft Mining stock is catching momentum as the company reports stronger gold and silver resources and clearer plans...
Microsoft kicks off 2026 with a rough start as earnings beat clashes with a surge in capital expenditures. Traders de...
Choosing a global ETF means balancing cost, diversification, and performance. This guide compares Vanguard VT and Sta...
A sharp upgrade, new AI partnerships, and a strategic move to Miami illuminate Palantir's potential. Learn how these ...
Markets are unsettled, but long-term investors can find value. This guide highlights three AI leaders that are curren...
Two fast-casual leaders headline the 2026 investor debate: a Mediterranean newcomer with fast expansion and a Mexican...
Stocks in the semiconductor sector led gains, with intel rallied today as investors weighed AI demand, supply chain p...
Berkshire Hathaway sits on a massive stock portfolio and a mountain of cash. As leadership quietly shifts, investors ...